21st Austria weekly – Marinomed, Wolford, Frequentis (12/04/2023)

Marinomed: Science-based biotech company Marinomed Biotech AG, listed on the Vienna Stock Exchange, announced further positive results from its clinical study on the anti-allergic properties of its…

<< Den vollständigen Artikel: 21st Austria weekly – Marinomed, Wolford, Frequentis (12/04/2023) >> hier vollständig lesen auf www.finanznachrichten.de.